NCT06692803View on ClinicalTrials.gov

Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy

CompletedOBSERVATIONAL
Enrollment

2,043

Participants

Timeline

Start Date

May 23, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Chronic Myeloid Leukemia
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY